Moreover, it was demonstrated that p53 mutations correlate with high expression of genes encoding for components of cholesterol biosynthesis in BC [164] that, considering high p53 mutation rate in TNBC [170], suggests that targeting cholesterol biosynthesis could be a treatment option for patients with TNBC. The gene discussed is TP53; the disease is breast cancer.